Cargando…
Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth
The oncogenic function of suppressor of variegation, enhancer of zeste and MYeloid-Nervy-DEAF1-domain family methyltransferase Smyd3 has been implicated in various malignancies, including hepatocellular carcinoma (HCC). Here, we show that targeting Smyd3 by next-generation antisense oligonucleotides...
Autores principales: | Kontaki, Haroula, Koukaki, Marina, Vasilarou, Maria, Giakountis, Antonis, Deligianni, Elena, Luo, Xiaolin, Kim, Youngsoo, Talianidis, Iannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169948/ https://www.ncbi.nlm.nih.gov/pubmed/34113819 http://dx.doi.org/10.1016/j.isci.2021.102473 |
Ejemplares similares
-
SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary Fibrosis
por: Elkouris, Maximilianos, et al.
Publicado: (2016) -
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021) -
Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy
por: van Deutekom, Judith, et al.
Publicado: (2023) -
Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models
por: Kim, Youngsoo, et al.
Publicado: (2019) -
The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases
por: Ulanova, Marina, et al.
Publicado: (2012)